Le Lézard
Classified in: Health, Covid-19 virus
Subject: PDT

Frontline Doctor Shares COVID-19 Rx in PANDEMIC MANIFESTO


EDISON, N.J., Oct. 20, 2020 /PRNewswire/ -- "The purpose of this manifesto is to teach you how to fish for accurate and reliable information today, tomorrow, and beyond," says Dr. Farah Fourcand, author of Pandemic Manifesto: COVID-19 Basic Training from the Frontlines. The newly released book available on www.drfarahmd.com uses clear, non-partisan language to walk readers through everything they need to know about COVID-19 and adapting to the new normal.

This COVID-19 manifesto teaches you how to fish for accurate and reliable information today, tomorrow, and beyond.

After reading Pandemic Manifesto, "people will be able to navigate almost any medical mystery, be empowered with knowledge to face the next pandemic with objective eyes, enhance their general understanding of medicine, and have the confidence to not let uncertainty and change be purveyors of fear and intimidation," says Dr. Fourcand.

Pandemic Manifesto takes a deep dive into viral basics, the history of pandemics, clinical trial design, evidence-based medicine, and the psychological impact of COVID-19. This creates a framework to answer key questions about COVID-19 including: 

Pandemic Manifesto exposes the realities behind vaccine development, testing, reinfection, hydroxychloroquine, ACE-inhibitor use, flattening the curve, PPE, herd immunity, mitigation, and reopening strategies. The science behind antibodies, the cytokine storm, ventilators, biomarkers, COVID-19's effects on different organ systems, and COVID-19 in men, children, certain blood types, obesity, and diabetes are explored. The modus operandi of plasma, remdesivir, tocilizumab, blood thinners, ECMO, steroids, melatonin, zinc, vitamin D, and other 'breakthrough' COVID-19 treatments are unmasked. Dr. Fourcand anticipates the dynamic nature of the current pandemic deserves a 'Part 2,' which she is currently working on in between ICU rounds and ER code brain bleeds. 

Dr. Fourcand is an NIH-trained, board-certified neurologist, stroke specialist, and neurocritical care and neurointerventional surgery fellow in New Jersey. She is the study director of a COVID-19 clinical trial designed to protect frontline healthcare workers. Dr. Fourcand is part of a COVID-19 'Brain Team' that stepped up and out of their comfort zone at the peak of the pandemic to make an impact.

Dr. Farah Fourcand, MD
Email: [email protected]
Website: www.drfarahmd.com  

SOURCE Dr. Farah Fourcand, MD


These press releases may also interest you

at 12:45
Leading research and experience management firm Sogolytics has released an original study examining the telehealth landscape, highlighting its achievements and challenges in providing positive experiences for patients. "It's critical for providers...

at 12:24
West Physics Consulting, LLC ("West Physics"), the leading national provider of integrated medical and health physics services, announced today that it has completed the purchase of the medical physics service division of Tricord, Inc. ("Tricord"), a...

at 12:16
Amae Health, a trailblazer in delivering patient-centered care for people with severe mental illness, announced today the successful closing of its oversubscribed $15 million Series A funding round. The round was led by Quiet Capital and included...

at 12:08
Roivios, a pioneering clinical-stage medical device company dedicated to transforming kidney health, is thrilled to announce it has been awarded the prestigious Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its...

at 12:06
Burrell College of Osteopathic Medicine (BCOM) attained the highest level of accreditation from the American Osteopathic Association (AOA) Commission on Osteopathic College Accreditation (COCA). Burrell has been awarded the prestigious accreditation...

at 12:05
Radiance Biopharma ("Radiance" or the "Company"), a biopharmaceutical company specializing in the development of novel Antibody Drug Conjugates (ADCs) and Bispecific ADCs (BsADCs) treatments for cancers, today announced that...



News published on and distributed by: